Interchangeable Biosimilars: Plan and Patient Savings
Adoption of biosimilars has been slow. The release of an FDA-approved interchangeable biosimilar may provide an added boost in savings. Read more.
- Reevaluate health benefits during open enrollment.
- Physician support of digital health tools has risen 8%.
- Recall on one lot of Propofol Injectable Emulsion.
- Philips Respironics sleep therapy masks recalled.
Published: September 29, 2022